Editas Expands CRISPR Capabilities through New Technology Licensing – Genetic Engineering & Biotechnology News
Boston Business Journal |
Editas Expands CRISPR Capabilities through New Technology Licensing
Genetic Engineering & Biotechnology News Officials at Editas Medicine say they exclusively licensed intellectual property related to new CRISPR technologies for human therapeutics. These global licensing agreements include intellectual property owned by the Broad Institute of MIT and Harvard … A better approach to gene editing? Editas snags new exclusive license from Broad Editas Medicine Inks Licensing Deals for CRISPR IP As Its Rivals Team Up, Editas Buys Next-Gen CRISPR From Old Friends |
